We are analyzing https://link.springer.com/article/10.1007/s00415-008-0778-x.

Title:
Clinical characteristics of patients with late-onset multiple sclerosis | Journal of Neurology
Description:
We evaluated clinical presentation, cerebrospinal fluid (CSF), and magnetic resonance imaging (MRI) in patients with late-onset multiple sclerosis (LOMS). Fifty-two patients with definitive multiple sclerosis (MS) diagnosed after the age of 50 years were identified between 1991 and 2002. Data pertaining to clinical characteristics, CSF analysis, and cerebral and spinal MRI were compared with those of 52 young-onset MS (YOMS) patients matched for sex and disease duration. Mean age at the time of diagnosis was 57 years in the LOMS group – the oldest patient was 82 – and 29 years in the YOMS group. Motor symptoms were significantly more often present in the LOMS than in patients with YOMS (90 % vs. 67 %, p = 0.014). Visual symptoms, residual signs of optic neuritis, and dysarthria were less frequent for LOMS. Sensory symptoms, ataxia, oculomotor symptoms, cognitive disorder, or fatigue did not differ between both groups. The majority of LOMS patients (83 %) had a primary progressive disease course, whereas 94 % of the YOMS group had a relapsing-remitting course. MRI showed typical multifocal supratentorial (LOMS vs. YOMS: 96 % vs. 98 %) and infratentorial (44 % vs. 62 %) lesions without significant group differences. Of particular interest, spinal lesions were more common (81 %) in LOMS compared to YOMS (48 %, p = 0.024), and cerebellar lesions were less frequent in the LOMS group (11 % vs. 44 %, p = 0.001). Gadolinium-enhanced lesions were initially present in less LOMS patients (15 %) than in YOMS (63 %, p < 0.001). CSF analysis revealed pleocytosis less frequently in LOMS (34 %) compared to YOMS (67 %, p = 0.006) but oligoclonal banding occurred without in both groups without differences. YOMS patients responded to corticosteroids (93 %) to a significantly greater degree than LOMS patients (73 %; p = 0.004). For individuals who develop LOMS, a primary progressive course is frequent, with motor symptoms as the prominent feature. Vigilance is necessary to recognise MS in this population because of its unusual presentation.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Social Networks
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

sclerosis, multiple, google, scholar, pubmed, article, cas, clinical, neurol, patients, loms, onset, yoms, neurology, age, primary, progressive, lateonset, kis, symptoms, late, privacy, cookies, content, data, journal, characteristics, rumberg, group, access, brain, analysis, information, publish, research, search, mri, spinal, lesions, acta, scand, confavreux, prognosis, disability, study, diagnostic, neurosurg, essen, log, berlit,

Topics {✒️}

month download article/chapter late-onset multiple sclerosis magnetic resonance imaging primary progressive disease full article pdf related subjects privacy choices/manage cookies gender-related effect definitive multiple sclerosis multiple sclerosis assessed multiple sclerosis based european economic area scope submit manuscript cerebrospinal fluid oligoclonal banding occurred mcdonnell gv long term follow van den noort alfried krupp hospital benign multiple sclerosis conditions privacy policy disease duration 52 young-onset ms late onset article journal geographically based study clinical episode suggestive assess clinical events accepting optional cookies ataxia gadolinium-enhanced lesions significantly greater degree check access rumberg contributed equally instant access article log early clinical predictors journal finder publish spinal cord injury clinical-epidemiological characteristics rheinische kliniken essen evaluated clinical presentation clinical variables important computerized data processing article kis recommended diagnostic criteria hawkins sa mcdonald wi research unit significant group differences

Questions {❓}

Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis?
Moreau T, Confavreux C (2000) Can the prognosis of multiple sclerosis be predicted?
Tremlett H, Devonshire V (2006) Is late-onset multiple sclerosis associated with a worse outcome?
Weinshenker BG (2000) Progressive forms of MS: classification streamlined or consensus overturned?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Clinical characteristics of patients with late-onset multiple sclerosis
         description:We evaluated clinical presentation, cerebrospinal fluid (CSF), and magnetic resonance imaging (MRI) in patients with late-onset multiple sclerosis (LOMS). Fifty-two patients with definitive multiple sclerosis (MS) diagnosed after the age of 50 years were identified between 1991 and 2002. Data pertaining to clinical characteristics, CSF analysis, and cerebral and spinal MRI were compared with those of 52 young-onset MS (YOMS) patients matched for sex and disease duration. Mean age at the time of diagnosis was 57 years in the LOMS group – the oldest patient was 82 – and 29 years in the YOMS group. Motor symptoms were significantly more often present in the LOMS than in patients with YOMS (90 % vs. 67 %, p = 0.014). Visual symptoms, residual signs of optic neuritis, and dysarthria were less frequent for LOMS. Sensory symptoms, ataxia, oculomotor symptoms, cognitive disorder, or fatigue did not differ between both groups. The majority of LOMS patients (83 %) had a primary progressive disease course, whereas 94 % of the YOMS group had a relapsing-remitting course. MRI showed typical multifocal supratentorial (LOMS vs. YOMS: 96 % vs. 98 %) and infratentorial (44 % vs. 62 %) lesions without significant group differences. Of particular interest, spinal lesions were more common (81 %) in LOMS compared to YOMS (48 %, p = 0.024), and cerebellar lesions were less frequent in the LOMS group (11 % vs. 44 %, p = 0.001). Gadolinium-enhanced lesions were initially present in less LOMS patients (15 %) than in YOMS (63 %, p < 0.001). CSF analysis revealed pleocytosis less frequently in LOMS (34 %) compared to YOMS (67 %, p = 0.006) but oligoclonal banding occurred without in both groups without differences. YOMS patients responded to corticosteroids (93 %) to a significantly greater degree than LOMS patients (73 %; p = 0.004). For individuals who develop LOMS, a primary progressive course is frequent, with motor symptoms as the prominent feature. Vigilance is necessary to recognise MS in this population because of its unusual presentation.
         datePublished:2008-02-19T00:00:00Z
         dateModified:2008-02-19T00:00:00Z
         pageStart:697
         pageEnd:702
         sameAs:https://doi.org/10.1007/s00415-008-0778-x
         keywords:
            multiple sclerosis
            age of onset
            cerebrospinal fluid
            magnetic resonance imaging
            Neurology
            Neurosciences
            Neuroradiology
         image:
         isPartOf:
            name:Journal of Neurology
            issn:
               1432-1459
               0340-5354
            volumeNumber:255
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Steinkopff-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:B. Kis
               affiliation:
                     name:Alfried Krupp Hospital
                     address:
                        name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
                        type:PostalAddress
                     type:Organization
                     name:Rheinische Kliniken Essen, Research Unit
                     address:
                        name:Dept. of Psychiatry, University of Duisburg-Essen, Rheinische Kliniken Essen, Research Unit, Essen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:B. Rumberg
               affiliation:
                     name:Alfried Krupp Hospital
                     address:
                        name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
                        type:PostalAddress
                     type:Organization
                     name:University of Duisburg-Essen
                     address:
                        name:Dept. of Diagnostic and Interventional, Radiology and Neuroradiology, University of Duisburg-Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Berlit
               affiliation:
                     name:Alfried Krupp Hospital
                     address:
                        name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Clinical characteristics of patients with late-onset multiple sclerosis
      description:We evaluated clinical presentation, cerebrospinal fluid (CSF), and magnetic resonance imaging (MRI) in patients with late-onset multiple sclerosis (LOMS). Fifty-two patients with definitive multiple sclerosis (MS) diagnosed after the age of 50 years were identified between 1991 and 2002. Data pertaining to clinical characteristics, CSF analysis, and cerebral and spinal MRI were compared with those of 52 young-onset MS (YOMS) patients matched for sex and disease duration. Mean age at the time of diagnosis was 57 years in the LOMS group – the oldest patient was 82 – and 29 years in the YOMS group. Motor symptoms were significantly more often present in the LOMS than in patients with YOMS (90 % vs. 67 %, p = 0.014). Visual symptoms, residual signs of optic neuritis, and dysarthria were less frequent for LOMS. Sensory symptoms, ataxia, oculomotor symptoms, cognitive disorder, or fatigue did not differ between both groups. The majority of LOMS patients (83 %) had a primary progressive disease course, whereas 94 % of the YOMS group had a relapsing-remitting course. MRI showed typical multifocal supratentorial (LOMS vs. YOMS: 96 % vs. 98 %) and infratentorial (44 % vs. 62 %) lesions without significant group differences. Of particular interest, spinal lesions were more common (81 %) in LOMS compared to YOMS (48 %, p = 0.024), and cerebellar lesions were less frequent in the LOMS group (11 % vs. 44 %, p = 0.001). Gadolinium-enhanced lesions were initially present in less LOMS patients (15 %) than in YOMS (63 %, p < 0.001). CSF analysis revealed pleocytosis less frequently in LOMS (34 %) compared to YOMS (67 %, p = 0.006) but oligoclonal banding occurred without in both groups without differences. YOMS patients responded to corticosteroids (93 %) to a significantly greater degree than LOMS patients (73 %; p = 0.004). For individuals who develop LOMS, a primary progressive course is frequent, with motor symptoms as the prominent feature. Vigilance is necessary to recognise MS in this population because of its unusual presentation.
      datePublished:2008-02-19T00:00:00Z
      dateModified:2008-02-19T00:00:00Z
      pageStart:697
      pageEnd:702
      sameAs:https://doi.org/10.1007/s00415-008-0778-x
      keywords:
         multiple sclerosis
         age of onset
         cerebrospinal fluid
         magnetic resonance imaging
         Neurology
         Neurosciences
         Neuroradiology
      image:
      isPartOf:
         name:Journal of Neurology
         issn:
            1432-1459
            0340-5354
         volumeNumber:255
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Steinkopff-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:B. Kis
            affiliation:
                  name:Alfried Krupp Hospital
                  address:
                     name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
                     type:PostalAddress
                  type:Organization
                  name:Rheinische Kliniken Essen, Research Unit
                  address:
                     name:Dept. of Psychiatry, University of Duisburg-Essen, Rheinische Kliniken Essen, Research Unit, Essen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:B. Rumberg
            affiliation:
                  name:Alfried Krupp Hospital
                  address:
                     name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
                     type:PostalAddress
                  type:Organization
                  name:University of Duisburg-Essen
                  address:
                     name:Dept. of Diagnostic and Interventional, Radiology and Neuroradiology, University of Duisburg-Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Berlit
            affiliation:
                  name:Alfried Krupp Hospital
                  address:
                     name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neurology
      issn:
         1432-1459
         0340-5354
      volumeNumber:255
Organization:
      name:Steinkopff-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Alfried Krupp Hospital
      address:
         name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
         type:PostalAddress
      name:Rheinische Kliniken Essen, Research Unit
      address:
         name:Dept. of Psychiatry, University of Duisburg-Essen, Rheinische Kliniken Essen, Research Unit, Essen, Germany
         type:PostalAddress
      name:Alfried Krupp Hospital
      address:
         name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
         type:PostalAddress
      name:University of Duisburg-Essen
      address:
         name:Dept. of Diagnostic and Interventional, Radiology and Neuroradiology, University of Duisburg-Essen, Essen, Germany
         type:PostalAddress
      name:Alfried Krupp Hospital
      address:
         name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:B. Kis
      affiliation:
            name:Alfried Krupp Hospital
            address:
               name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
               type:PostalAddress
            type:Organization
            name:Rheinische Kliniken Essen, Research Unit
            address:
               name:Dept. of Psychiatry, University of Duisburg-Essen, Rheinische Kliniken Essen, Research Unit, Essen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:B. Rumberg
      affiliation:
            name:Alfried Krupp Hospital
            address:
               name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
               type:PostalAddress
            type:Organization
            name:University of Duisburg-Essen
            address:
               name:Dept. of Diagnostic and Interventional, Radiology and Neuroradiology, University of Duisburg-Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      name:P. Berlit
      affiliation:
            name:Alfried Krupp Hospital
            address:
               name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
      name:Dept. of Psychiatry, University of Duisburg-Essen, Rheinische Kliniken Essen, Research Unit, Essen, Germany
      name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
      name:Dept. of Diagnostic and Interventional, Radiology and Neuroradiology, University of Duisburg-Essen, Essen, Germany
      name:Dept. of Neurology, Alfried Krupp Hospital, Essen, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(121)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.14s.

LINK . SPRINGER . COM {}